Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nichols

Showing results (861-870 of 973) with videos related to

Pageof 98
Sort By:
Chest|June 19, 2007
Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?Douglas R Stewart, Joy D Cogan, Mordechai R Kramer, et al.
Blood|November 24, 2005
Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2Bin Zhang, Beth McGee, Jennifer S Yamaoka, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Journal of Medical Imaging and Radiation Sciences|October 12, 2021
Implementation and evaluation of an online anatomy, radiology and contouring bootcamp for radiation therapistsKrista D'Angelo, Paige Eansor, Leah A D'Souza, et al.
Plos One|September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer modelsNicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Head & Neck|February 21, 2022
Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancerHugh A J Kim, Peter Y F Zeng, Alana Sorgini, et al.
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Long-Term Survival and CANARY-Based Artificial Intelligence for Multifocal Lung AdenocarcinomaSahar A Saddoughi, Chelsea Powell, Gregory R Stroh, et al.
Pageof 98

Showing results (861-870 of 973) with videos related to

Sort By:
Pageof 98
Chest|June 19, 2007
Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?Douglas R Stewart, Joy D Cogan, Mordechai R Kramer, et al.
Blood|November 24, 2005
Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2Bin Zhang, Beth McGee, Jennifer S Yamaoka, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Journal of Medical Imaging and Radiation Sciences|October 12, 2021
Implementation and evaluation of an online anatomy, radiology and contouring bootcamp for radiation therapistsKrista D'Angelo, Paige Eansor, Leah A D'Souza, et al.
Plos One|September 24, 2020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer modelsNicole Pinto, Stephenie D Prokopec, Farhad Ghasemi, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Head & Neck|February 21, 2022
Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancerHugh A J Kim, Peter Y F Zeng, Alana Sorgini, et al.
Mayo Clinic Proceedings. Digital Health|April 10, 2025
Long-Term Survival and CANARY-Based Artificial Intelligence for Multifocal Lung AdenocarcinomaSahar A Saddoughi, Chelsea Powell, Gregory R Stroh, et al.
Pageof 98